Browsing by Author Orlowski, Robert Z

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2017Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trialJoshua, Douglas; Chng, W-J; Dimopoulos, Meletios A; et al, Various; Facon, Thierry; Goldschmidt, Hartmut; Hajek, Roman; Ludwig, Heinz; Niesvizky, R.; Oriol, Albert; Orlowski, Robert Z; Central Clinical School: MedicineCarfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial, The Lancet Oncology, vol.18, 10, 2017,pp 1327-1337
2016International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal ImpairmentJoshua, Douglas; Dimopoulos, Meletios A; Durie, Brian G M; et al, Various; Garderet, Laurent; Goldschmidt, Hartmut; Kastritis, Efstathios; Leung, Nelson; Ludwig, Heinz; Merlini, Giampaolo; Orlowski, Robert Z; Powles, Ray; Rajkumar, S Vincent; Richardson, Paul G; Sonneveld, Pieter; Vesole, David H.; Central Clinical School: MedicineInternational Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment, Journal of Clinical Oncology, vol.34, 13, 2016,pp 1544-1557